Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Zydus Cadila gets USFDA nod to Potassium Chloride ER Capsules to prevent hypokalemia

      Zydus Cadila gets USFDA nod to Potassium Chloride ER Capsules to prevent hypokalemia

      Farhat Nasim13 March 2019 9:45 AM IST
      Zydus Cadila said that the Potassium Chloride extended-release capsules will be manufactured at the group's formulations manufacturing facility at...
      Seres Therapeutics, Astrazeneca to collaborate on microbiome immuno oncology

      Seres Therapeutics, Astrazeneca to collaborate on microbiome immuno oncology

      Farhat Nasim13 March 2019 9:15 AM IST
      Under the terms of the exclusive collaboration, AstraZeneca will provide Seres Therapeutics with $20 million in three equal instalments over two...
      Embracing the Vegetarian Lifestyle: 5 Habits You Need to Have Right Away

      Embracing the Vegetarian Lifestyle: 5 Habits You Need to Have Right Away

      Farhat Nasim13 March 2019 9:00 AM IST
      New Delhi: If you are a meat lover, ‘vegetarian’ might sound like a dirty word with ten unwanted letters. But you will have to admit the fact that...
      Laurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malaria

      Laurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malaria

      Farhat Nasim12 March 2019 12:01 PM IST
      Hydroxychloroquine tablet is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other...
      Pfizer biosimilar to Roche Herceptin wins USFDA nod

      Pfizer biosimilar to Roche Herceptin wins USFDA nod

      Farhat Nasim12 March 2019 9:45 AM IST
      The approval for Pfizer comes nearly a year after the agency declined to approve the drug, Trazimera, and sought additional technical information. The...
      USFDA approves use of Regeneron, Sanofi eczema drug Dupixent in adolescents

      USFDA approves use of Regeneron, Sanofi eczema drug Dupixent in adolescents

      Farhat Nasim12 March 2019 9:30 AM IST
      Dupixent was initially approved in 2017 and has since been launched in the United States as a treatment for adults with moderate-to-severe atopic...
      Integra Lifesciences Boston plant gets USFDA warning letter

      Integra Lifesciences Boston plant gets USFDA warning letter

      Farhat Nasim12 March 2019 9:15 AM IST
      The warning letter was issued after an inspection held at the facility in October and November last year, and does not restrict the company's ability...
      Unichem Labs Ghaziabad facility successfully completes USFDA inspection

      Unichem Labs Ghaziabad facility successfully completes USFDA inspection

      Farhat Nasim11 March 2019 9:45 AM IST
      The US Food and Drug Administration (USFDA) conducted an inspection of the company's Ghaziabad facility from March 3-8, 2019, and it has been...
      USFDA accepts Allergan license applications to expand Botox label

      USFDA accepts Allergan license applications to expand Botox label

      Farhat Nasim11 March 2019 9:30 AM IST
      "The FDA's acceptance of Allergan's supplemental biologics license applications is a monumental milestone on our journey to bring new treatment...
      Pharmaceutical firms request to delay opioid trial refused

      Pharmaceutical firms request to delay opioid trial refused

      Farhat Nasim11 March 2019 9:15 AM IST
      Attorneys for the drug companies say that they need more time to prepare for opioid trial and that they may appeal to the state Supreme Court. Purdue...
      Dutch hospital join backlash at expensive medicines by making their own

      Dutch hospital join backlash at expensive medicines by making their own

      Farhat Nasim11 March 2019 9:00 AM IST
      "People with rare diseases are dependent on medicines that are so expensive that they can't afford them when they could be offered for a much lower...
      Online pharmacy loses medicines worth Rs 11 lakh to theft

      Online pharmacy loses medicines worth Rs 11 lakh to theft

      Farhat Nasim10 March 2019 12:44 PM IST
      Bangalore: A shocking revelation comes for the one of the country's largest online pharmacy, Medlife International Private Limited as two of its...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok